Search results
GSK Discovered Vaccine That Protects Against RSV, Paul Singer
Dealbreaker· 5 days agoPaul Singer may or may not have become a nicer person over the last few years, but that doesn’t mean...
A Call to Action: Improving Uptake of Lung Cancer Screening
Medscape· 5 days agoDr Maurie Markman discusses the proportion of eligible patients who obtain lung cancer screening.
Infinant Health Appoints New Team Members to assist with Drug Development
FOX21 Colorado Springs· 4 days agoInfinant Health, a privately-held company focused on changing the trajectory of human health by supporting the development and restoration of the immune system via the gut microbiome, announces ...
Explainer-What to know about bird flu in dairy cows and the risk to humans By Reuters
Investing.com· 4 days agoCHICAGO (Reuters) -A second human case of bird flu was confirmed in a dairy worker in Michigan, U.S....
23andMe Fiscal Q4 Revenues Drop 31 Percent as Research Services, Genetic Test Kit Sales Shrink
GenomeWeb News· 2 days agoThe firm attributed the decrease largely to lower research services revenue due to ending a collaboration with GlaxoSmithKline, as well as lower consumer services revenue ...
GSK whistleblower claims drugmaker cheated US government over Zantac cancer risk
Reuters· 6 days ago, opens new tab has been sued by an independent Connecticut laboratory that accused the drugmaker of...
Tempus, Chicago's biotech darling, files to go public
Crain s Chicago Business· 6 days agoAfter several years of speculation Tempus would go public, the AI-enabled precision-medicine startup from Eric Lefkofsky filed for an initial public offering today. The company, founded in 2015 ...
GSK whistleblower claims drugmaker cheated US government over Zantac cancer risk By Reuters
Investing.com· 6 days agoIn a whistleblower complaint filed on Monday, Valisure said GSK violated the federal False Claims...
AI Is Deciphering Your Corporate Trade Secrets
Forbes· 4 days agoIn the high-stakes world of corporate competition, trade secrets are the hidden gems that give companies their competitive edge. AI's ability to analyze, learn, and decipher complex patterns ...
GSK says late-stage trials of potential blockbuster asthma drug met their goals
Morningstar· 5 days agoGSK on Tuesday said two late-stage trials of an asthma drug that could have peak sales of more than GBP3 billion ($3.8 billion) met their goals. GSK (GSK) (UK:GSK) said both trials of depemokimab ...
